be Medical
9
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
22.2%
2 terminated/withdrawn out of 9 trials
71.4%
-15.1% vs industry average
11%
1 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Belgian Prospective Multicentre Registry to Evaluate Safety and Performance of the Optimed Stent in the Superficial Femoral Artery
Role: lead
Treatment of Varicose Veins With the ELVeS® Radial® 2ring Slim Fiber. Are There Limitations?
Role: lead
Endovascular Treatment of Peripheral Artery Disease
Role: lead
Evaluation of the Sinus-Venous Stent for the Treatment of Iliofemoral Venous Occlusive Disease
Role: lead
Endovascular Treatment of Atherosclerotic Lesions in the SFA Using the Sinus-superflex-635 Stent
Role: lead
Remedy, Biodegradable Peripheral Stent Registry
Role: lead
Safety and Performance of the Zeus CC Stent for the Treatment of Iliac Occlusive Disease
Role: lead
Laparoscopic and Open Ventral Hernia Repair Using the Intramesh T1
Role: lead
Safety and Effectiveness of the Coronary Momo Stent
Role: lead
All 9 trials loaded